Envelope proteins of two HIV-1 clades induced different epitope-specific antibody response
- PMID: 29429810
- DOI: 10.1016/j.vaccine.2018.01.081
Envelope proteins of two HIV-1 clades induced different epitope-specific antibody response
Abstract
Using HIV-1 envelope protein (Env)-based immunogens that closely mimic the conformation of functional HIV-1 Envs and represent the isolates prevalent in relevant geographical region is considered a rational approach towards developing HIV vaccine. We recently reported that like clade B Env, JRFL, membrane bound Indian clade C Env, 4-2.J41 is also efficiently cleaved and displays desirable antigenic properties for plasmid DNA immunization. Here, we evaluated the immune response in rabbit by injecting the animals with plasmid expressing membrane bound efficiently cleaved 4-2.J41 Env followed by its gp140-foldon (gp140-fd) protein boost. The purified 4-2.J41-gp140-fd protein is recognized by a wide panel of broadly neutralizing antibodies (bNAbs) including the quaternary conformation-dependent antibody, PGT145 with high affinity. We have also evaluated and compared the quality of antibody response elicited in rabbits after immunizing with plasmid DNA expressing the membrane bound efficiently cleaved Env followed by gp140-fd proteins boost with either of clade C Env, 4-2.J41 or clade B Env, JRFL or in combination. In comparison to JRFL group, 4-2.J41 group elicited autologous as well as limited low level cross clade neutralizing antibody response. Preliminary epitope-mapping of sera from animals show that in contrast to JRFL group, no reactivity to either linear peptides or V3-loop is detected in 4-2.J41 group. Furthermore, the presence of conformation-specific antibody in sera from animals immunized with 4-2.J41 Env is observed. However, unlike JRFL group, in 4-2.J41 group of animals, CD4-binding site-directed antibodies cannot be detected. Additionally, we have demonstrated that the quality of antibody response in combination group is guided by JRFL Env-based immunogen suggesting that the selection and the quality of Envs in multicade candidate vaccine are important factors to elicit desirable response.
Keywords: HIV-1 Indian clade C; Monovalent/bivalent immunization; Neutralizing antibody; Vaccine; gp140-foldon trimer.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
Membrane bound modified form of clade B Env, JRCSF is suitable for immunogen design as it is efficiently cleaved and displays all the broadly neutralizing epitopes including V2 and C2 domain-dependent conformational epitopes.Retrovirology. 2016 Nov 21;13(1):81. doi: 10.1186/s12977-016-0312-7. Retrovirology. 2016. PMID: 27871328 Free PMC article.
-
Cell surface ectodomain integrity of a subset of functional HIV-1 envelopes is dependent on a conserved hydrophilic domain containing region in their C-terminal tail.Retrovirology. 2018 Jul 20;15(1):50. doi: 10.1186/s12977-018-0431-4. Retrovirology. 2018. PMID: 30029604 Free PMC article.
-
Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.J Virol. 2016 Jan 13;90(7):3446-57. doi: 10.1128/JVI.03090-15. J Virol. 2016. PMID: 26763999 Free PMC article.
-
The Neutralizing Antibody Response to the HIV-1 Env Protein.Curr HIV Res. 2018;16(1):21-28. doi: 10.2174/1570162X15666171124122044. Curr HIV Res. 2018. PMID: 29173180 Free PMC article. Review.
-
HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth.Retrovirology. 2018 Nov 26;15(1):74. doi: 10.1186/s12977-018-0457-7. Retrovirology. 2018. PMID: 30477581 Free PMC article. Review.
Cited by
-
The Versatile Manipulations of Self-Assembled Proteins in Vaccine Design.Int J Mol Sci. 2021 Feb 16;22(4):1934. doi: 10.3390/ijms22041934. Int J Mol Sci. 2021. PMID: 33669238 Free PMC article. Review.
-
Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model.Front Immunol. 2021 May 24;12:641447. doi: 10.3389/fimmu.2021.641447. eCollection 2021. Front Immunol. 2021. PMID: 34108961 Free PMC article.
-
Tetramerizing tGCN4 domain facilitates production of Influenza A H1N1 M2e higher order soluble oligomers that show enhanced immunogenicity in vivo.J Biol Chem. 2020 Oct 16;295(42):14352-14366. doi: 10.1074/jbc.RA120.013233. Epub 2020 Aug 13. J Biol Chem. 2020. PMID: 32817314 Free PMC article.
-
The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41.Int Immunopharmacol. 2021 Dec;101(Pt B):108187. doi: 10.1016/j.intimp.2021.108187. Epub 2021 Sep 28. Int Immunopharmacol. 2021. PMID: 34649114 Free PMC article.
-
Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus.Int Immunopharmacol. 2021 Oct;99:108020. doi: 10.1016/j.intimp.2021.108020. Epub 2021 Jul 29. Int Immunopharmacol. 2021. PMID: 34426117 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials